Clinical Trials List
Protocol NumberCLNP023F12301
Completed
2021-07-15 - 2026-12-31
Phase III
Recruiting2
ICD-10D59.3
Hemolytic-uremic syndrome
ICD-9283.11
Non-autoimmune hemolytic anemias, Hemolytic-uremic syndrome
-
Trial Applicant
NOVARTIS (TAIWAN) CO., LTD.
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/07/01
Investigators and Locations
Co-Principal Investigator
- Guan-Hsing Chen Division of Nephrology
- Ya-Chung Tian Division of Nephrology
- 鄭昌錡 Division of Nephrology
- Cheng-Chia Lee Division of Nephrology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 謝明翰 Division of Nephrology
- 陳怡儒 Division of Nephrology
- Ping-Chin Lai Division of Nephrology
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
18 participants
-
Global
50 participants
